You are viewing: North America Pharmaceutical Packaging Market analysis

The North America Pharmaceutical Packaging Market was valued at $6657 Million in 2025 and projected to reach to $15106.9 Million by 2030, representing a compound annual growth rate of 17.8%. North America's pharmaceutical packaging market is poised for substantial growth through 2030, driven by increasing regulatory pressures, the rise of personalized medicine, and growing demand for sustainable packaging solutions.

North America Pharmaceutical Packaging Market Trends and Insights

  • Asia Pacific's 17.8% compound annual growth rate significantly outpaces global trends, driven by rising pharmaceutical manufacturing capacity, increasing regulatory compliance requirements, and growing demand for advanced packaging solutions across the region.
  • The market in Asia Pacific is benefiting from rapid industrialization, expanding healthcare infrastructure, and a surge in generic drug production that demands innovative, cost-effective packaging technologies. Asia Pacific's pharmaceutical packaging sector is characterized by heightened competition among regional and international players seeking to capture market share in this high-growth geography.
  • The region's pharmaceutical companies are increasingly investing in sustainable packaging materials and smart packaging technologies to meet both consumer expectations and stringent regulatory standards.
  • By 2030, Asia Pacific is expected to solidify its position as a critical hub for pharmaceutical packaging innovation, with emerging economies driving incremental volume growth and established markets driving premiumization and technological advancement..

Key Market Statistics

  • CAGR (2025-2030) 17.8% CAGR
  • Market Size, 2025 ~USD 6657 Million
  • Forecast, 2030 ~USD 15106.9 Million
  • Geography North America

North America Pharmaceutical Packaging Market Overview

Dominant US Market Leadership :

The US pharmaceutical packaging market commands USD 84,682.9 million, representing the largest regional opportunity with advanced manufacturing infrastructure and stringent FDA compliance driving premium packaging solutions.

Strong Regional CAGR Performance :

North America's 17.8% CAGR significantly exceeds the global average of 15.8%, reflecting accelerated adoption of innovative packaging technologies and increased biopharmaceutical production capacity across the region.

Canada's Growing Contribution :

Canada's pharmaceutical packaging market valued at USD 20,216.7 million demonstrates robust growth potential, supported by expanding generic drug manufacturing and cross-border supply chain integration with the US.

Mexico's Emerging Opportunity :

Mexico's USD 9,428.9 million market presents significant expansion potential as nearshoring trends accelerate pharmaceutical manufacturing, creating demand for compliant and cost-effective packaging solutions.

North America Pharmaceutical Packaging Market Dynamics

  • The region's mature healthcare infrastructure and advanced manufacturing capabilities position it as a global innovation hub for packaging technologies.
  • Biopharmaceutical companies are investing heavily in specialized packaging for complex drug delivery systems, while compliance with evolving FDA and Health Canada regulations continues to elevate packaging standards.
  • The integration of smart packaging technologies and eco-friendly materials reflects industry-wide commitment to safety and sustainability.
  • Nearshoring trends and supply chain resilience initiatives further strengthen North America's market position, with Mexico emerging as a key manufacturing hub complementing US and Canadian operations..

Related Ecosystem

Resins And Polymers

Top Technologies
  • Polycarbonate
  • Acrylonitrile Butadiene Styrene (ABS)
  • Epoxy Resin
  • Light Commercial Vehicles (LCVs)
  • Polypropylene (PP)
Top Companies
  • Basf se
  • DOW CHEMICAL COMPANY
  • Solvay sa
  • Saudi arabia basic industries corporation (sabic)
  • DuPont de Nemours, Inc.

    Pharmaceuticals

    Top Technologies
    • Bioreactors
    • Analytical Testing
    • Bioanalytical Testing Services
    • Cell Counters
    • Data Management Services
    Top Companies
    • Merck KGaA
    • Thermo Fisher Scientific Inc.
    • SANOFI
    • NOVARTIS
    • Pfizer Inc.

      Packaging

      Top Technologies
      • Ampoules
      • Gravure Process
      • Rigid Packaging
      • Aerosols
      • Aseptic Filling and Sealing Equipment
      Top Companies
      • Amcor plc
      • Essentra plc
      • Berry Global Group, Inc.
      • Mondi plc
      • SEALED AIR CORPORATION

        Key Takeaways

        • Asia Pacific pharmaceutical packaging market will more than double from USD 6,657.0M (2025) to USD 15,106.9M (2030), growing at 17.8% CAGR.
        • Asia Pacific's growth rate of 17.8% significantly exceeds the global CAGR of 15.8%, positioning the region as the fastest-growing pharmaceutical packaging market.
        • Asia Pacific's expansion is fueled by increased pharmaceutical manufacturing, regulatory compliance demands, and adoption of advanced packaging technologies across emerging and developed economies.
        • By 2030, Asia Pacific is projected to become a dominant center for pharmaceutical packaging innovation, with emphasis on sustainability and smart packaging solutions.

        Pharmaceutical Packaging Market Report Scope

        Report Metric Details
        Base Year 2025
        Fastest Growing Segment PREFILLED SYRINGES (Type)
        Forecast Period 2025–2030
        Growth Rate CAGR of 15.8% from 2025 to 2030
        Largest Segment INJECTABLE (Drug Delivery)
        Market Size Base Year (Billions) ~USD 174.86 (2025)
        Revenue Forecast (Billions) ~USD 364.11 (2030)
        Segments Covered Raw Material, Drug Delivery, Type, Packaging Type, Drug Delivery Mode

        North America Pharmaceutical Packaging Market Report Segmentation

        5 segment dimensions are covered across the global market.

        By Raw Material

        • Glass
        • Metal
        • Other Raw Materials
        • Paper & Paperboard
        • Plastic
        • Plastics

        By Drug Delivery

        • Injectable
        • Injectables
        • Intravenous
        • Nasal
        • Ocular/Ophthalmic
        • Oral
        • Oral Drugs
        • Other Drug Delivery Modes
        • Pulmonary
        • Topical
        • Transdermal

        By Type

        • Ampoules
        • Blister Packs
        • Caps & Closures
        • Cartridges
        • Jars & Canisters
        • Labels & Accessories
        • Medical Specialty Bags
        • Medication Tubes
        • Other Types
        • Plastic Bottles
        • Pouches & Strip Packs
        • Pouches & Strips
        • Prefilled Inhalers
        • Prefilled Syringes
        • Temperature-Controlled Packaging
        • Vials

        By Packaging Type

        • Primary
        • Secondary

        By Drug Delivery Mode

        • Injectable
        • Intravenous
        • Nasal
        • Ocular/Ophthalmic
        • Oral
        • Other Drug Delivery Modes
        • Pulmonary
        • Topical
        • Transdermal

        Target Audience

        • Pharmaceutical Manufacturers : Optimize packaging procurement strategies, evaluate supplier capabilities across North America, and align production with regional regulatory requirements and market demand forecasts.
        • Packaging Solution Providers : Identify growth opportunities in US, Canadian, and Mexican markets; benchmark competitive positioning; and develop targeted product innovation roadmaps for pharmaceutical applications.
        • Investment & Private Equity Firms : Evaluate M&A targets, assess market consolidation potential, and identify high-growth segments within North America's USD 114.3 billion pharmaceutical packaging opportunity.
        • Regulatory & Compliance Officers : Stay informed on evolving FDA, Health Canada, and COFEPRIS packaging standards; assess compliance costs; and benchmark best practices across North American operations.
        • Supply Chain & Procurement Strategists : Optimize sourcing decisions, evaluate nearshoring opportunities in Mexico, and develop resilient supplier networks aligned with North America's 17.8% market growth trajectory.

        Key Companies in the North America Pharmaceutical Packaging Market

        CompanyHQOwnershipStrongest segments
        TASNEESaudi ArabiaPublic CompanyPetrochemicals (PE, PP compounds, acrylics, solvents),Metallurgy (titanium sponge, slag, pig iron, lead),Downstream plastics (BOPP films, pipes, pallets, agrifilm, sheets, liners),
        LG CHEM LTD.South KoreaPublic CompanyEthylene- and propylene-based synthetic resins,Styrene-based resins and polycarbonate,Advanced materials and battery-related chemistries,
        BOBST GROUP SASwitzerlandPrivate CompanyFolding carton converting (flatbed die-cutters, folder-gluers, related tooling and services),Corrugated board equipment (flexo printing, rotary die-cutters, folder-gluers, converting lines),Flexible packaging and label equipment (vacuum metallizers, coating/laminating, CI/inline flexo, gravure, digital),
        GERRESHEIMER AGGermanyPublic CompanyPrimary Packaging Glass (vials, cartridges, ampoules, flacons),Plastics & Devices (syringes, bottles, closures, medical disposables),Advanced Technologies & Drug Delivery Devices,
        SCHOTT AGGermanyPublic CompanyPrefillable glass syringes (syriQ portfolio),Pharmaceutical glass vials (adaptiQ, EVERIC family),Cartridges (cartriQ and related),
        APTARGROUP, INC.United StatesPublic CompanyPharma (drug delivery, elastomeric components, active material science, digital health),Beauty (fragrance, facial skincare, color cosmetics dispensing),Closures (food, beverage, personal and home care closures and aerosol valves),
        BDUnited StatesPublic Company
        WESTROCK COMPANYUnited StatesPrivate CompanyConsumer packaging solutions,Corrugated packaging solutions,Merchandising display solutions,

        TASNEE

        TASNEE is a Saudi Arabian public company founded in 1984 with 7,000 employees, operating in the petrochemicals and industrial materials industry.

        LG CHEM LTD.

        LG Chem Ltd. is a South Korean public company founded in 1947 with 14,019 employees, specializing in chemicals, advanced materials, and energy solutions.

        BOBST GROUP SA

        Bobst Group SA is a Swiss private company founded in 1890 with 6,314 employees, manufacturing machinery and equipment for the packaging and printing industries.

        GERRESHEIMER AG

        Gerresheimer AG is a German public company founded in 1864 with 13,528 employees, manufacturing specialty glass and plastic packaging for pharmaceuticals and cosmetics.

        SCHOTT AG

        Schott AG is a German public company founded in 1884 with 4,839 employees, producing specialty glass and glass-ceramics for various industrial applications.

        APTARGROUP, INC.

        AptarGroup, Inc. is a United States public company founded in 1992 with 14,000 employees, manufacturing dispensing systems and packaging solutions for beauty, personal care, and pharmaceutical markets.

        BD

        BD (Becton, Dickinson and Company) is a United States public company founded in 1897 with 72,000 employees, specializing in medical devices, diagnostics, and laboratory equipment.

        WESTROCK COMPANY

        WestRock Company is a United States private company founded in 2018 with 56,100 employees, operating as a major manufacturer of paper and packaging products.

        North America vs. other regions

        HowNorth America compares to the other 3 regional blocs covered in this market.

        Global
        ~USD 13678.4 Million · 15.2% wtd CAGR ·
        Europe
        ~USD 2136.3 Million · 16.8% wtd CAGR ·
        Asia Pacific
        ~USD 3477.1 Million · 17.2% wtd CAGR ·
        Middle East & Africa
        ~USD 9712.5 Million · 15.2% wtd CAGR ·
        South America
        ~USD 18109.2 Million · 17% wtd CAGR ·

        Countries within North America - compare and drill down

        Country2025 size (native)
        USUSD 84682.9 Million
        CanadaUSD 20216.7 Million
        MexicoUSD 9428.9 Million

        Country market size visualization

        US
        USD 84682.9 Million
        Canada
        USD 20216.7 Million
        Mexico
        USD 9428.9 Million

        Reasons to Buy this Report

        • Country-Level Market Granularity : Access detailed market sizing for US (USD 84,682.9M), Canada (USD 20,216.7M), and Mexico (USD 9,428.9M) to identify high-growth segments and regional investment opportunities.
        • Regulatory Compliance Intelligence : Understand FDA, Health Canada, and COFEPRIS requirements driving packaging innovation and compliance costs across North America's pharmaceutical supply chain.
        • Competitive Landscape Analysis : Benchmark against regional competitors and identify market consolidation trends, technology leaders, and emerging players reshaping North American pharmaceutical packaging.
        • Nearshoring & Supply Chain Insights : Capitalize on Mexico's manufacturing growth and US-Canada integration strategies to optimize sourcing, reduce lead times, and strengthen supply chain resilience.
        • Technology & Innovation Trends : Discover adoption rates of smart packaging, sustainable materials, and advanced delivery systems driving premium pricing and market differentiation in North America.

        Frequently asked questions

        What is the current size of the Asia Pacific pharmaceutical packaging market in 2025?

        The Asia Pacific pharmaceutical packaging market is valued at USD 6,657.0 million in 2025, representing a significant portion of global pharmaceutical packaging demand.

        What is the projected market size for Asia Pacific pharmaceutical packaging by 2030?

        Asia Pacific pharmaceutical packaging market is forecast to reach USD 15,106.9 million by 2030, more than doubling its 2025 valuation.

        What is the CAGR for Asia Pacific pharmaceutical packaging market?

        Asia Pacific pharmaceutical packaging market is expected to grow at a compound annual growth rate of 17.8% from 2025 to 2030.

        How does Asia Pacific's growth compare to the global pharmaceutical packaging market?

        Asia Pacific's CAGR of 17.8% outpaces the global CAGR of 15.8%, making it the fastest-growing region for pharmaceutical packaging.

        What factors are driving growth in Asia Pacific pharmaceutical packaging?

        Key drivers include rising pharmaceutical manufacturing capacity, stringent regulatory compliance requirements, increased generic drug production, rapid industrialization, and growing adoption of sustainable and smart packaging technologies.

        RESEARCH METHODOLOGY

        The study involved four major activities to estimate the current size of the global pharmaceutical packaging market. Exhaustive secondary research was carried out to collect information on the market, the peer product market, and the parent product group market. The next step was to validate these findings, assumptions, and sizes with the industry experts across the value chain of pharmaceutical packaging through primary research. The top-down and bottom-up approaches were employed to estimate the overall size of the pharmaceutical packaging market. After that, market breakdown and data triangulation procedures were used to determine the size of different segments and sub-segments of the market.

        Secondary Research

        The market for the companies offering pharmaceutical packaging is arrived at by secondary data available through paid and unpaid sources, analyzing the product portfolios of the major companies in the ecosystem, and rating the companies by their performance and quality. Various secondary sources, such as Business Standard, Bloomberg, World Bank, and Factiva, were referred to in order to identify and collect information for this study on the pharmaceutical packaging market. In the secondary research process, various secondary sources were referred to identify and collect information related to the study. Secondary sources included annual reports, press releases, and investor presentations, forums, certified publications, and whitepapers. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and technology-oriented perspectives.

        Primary Research

        In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side included industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), marketing directors, technology and innovation directors, and related key executives from several key companies and organizations operating in the pharmaceutical packaging market. After the complete market engineering (calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. Primary research was also conducted to identify the segmentation types, industry trends, competitive landscape of pharmaceutical packaging offered by various market players, and key market dynamics, such as drivers, restraints, opportunities, challenges, industry trends, and key player strategies. In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

        Pharmaceutical Packaging Market Size, and Share

        Notes: Other designations include sales, marketing, and product managers.
        Tier 1: Revenues greater than USD 1 Billion; Tier 2: Revenues between USD 500 million and USD 1
        Billion; and Tier 3: Revenues less than USD 500 million

        To know about the assumptions considered for the study, download the pdf brochure

        Market Size Estimation

        The top-down and bottom-up approaches were used to estimate and validate the size of the global pharmaceutical packaging market. These approaches were also used extensively to estimate the size of various dependent market segments. The research methodology used to estimate the market size included the following:

        Pharmaceutical Packaging Market : Top-Down and Bottom-Up Approach

        Pharmaceutical Packaging Market Top Down and Bottom Up Approach

        Data Triangulation

        After arriving at the overall market size using the market size estimation processes, the market was split into several segments and subsegments. The data triangulation procedure was employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment. The data was triangulated by studying various factors and trends from both the demand and supply sides.

        Market Definition

        Pharmaceutical packaging pertains to the materials and systems designed to protect, preserve, and deliver pharmaceutical products for oral, injectable, inhalation, and topical drug delivery modalities. It plays an important role in the stability and sterility of a drug, avoids contamination, and provides accurate dosing for the life of the product. Pharmaceutical packaging denotes the numerous varieties of available options, like plastic bottles, blister packs, vials, ampoules, prefillable syringes, tubes, pouches, and cartons to meet drug formulation requirements and regulatory obligations. Some of the significant functionalities of pharmaceutical packaging include moisture, oxygen, and light barrier protection, tamper evidence, patient convenience, and functionality with active pharmaceutical ingredients (APIs).

        Areas of interest include ISO 15378 relating specifically to primary packaging materials, ISO 9001 regarding quality management systems, and GMP compliance. The DSCSA and the EU FMD identified serialized, tracking, and anti-counterfeiting programs, creating an opportunity for the packaging industry to help with drug quality and patient safety.

        Stakeholders

        • Pharmaceutical packaging manufacturers
        • Raw material suppliers
        • Converters & processors
        • Distributors and traders
        • Industry associations and regulatory bodies
        • End users

        Report Objectives

        • To define, describe, and forecast the size of the pharmaceutical packaging market, based  on type, packaging type, drug delivery, raw material, and region in terms of value and volume
        • To provide detailed information on the significant drivers, restraints, opportunities, and challenges influencing the market
        • To strategically analyze micromarkets concerning individual growth trends, prospects, and their contribution to the market
        • To assess the growth opportunities in the market for stakeholders and provide details on the competitive landscape for market leaders
        • To forecast the market size of segments and subsegments for North America, Europe, Asia Pacific, South America, and the Middle East & Africa
        • To strategically profile key players and comprehensively analyze their market shares and core competencies
        • To analyze competitive developments such as acquisitions, product launches, expansions, partnerships, and agreements in the pharmaceutical packaging market
        • To provide the impact of AI/Gen AI on the market

        Available Customizations

        With the given market data, MarketsandMarkets offers customizations according to client-specific needs.

        The following customization options are available for the pharmaceutical packaging market report:

        Product Analysis

        • A product matrix that gives a detailed comparison of the product portfolio of each company

        Geographic Analysis as per Feasibility

        • A further breakdown of the pharmaceutical packaging market for additional countries

        Company Information

        • Detailed analysis and profiling of additional market players (up to five)

        Get the Full Pharmaceutical Packaging Market Report

        Full forecast, segment splits, and company analysis for all Pharmaceutical Packaging Market.

        Need a Tailored Report?

        Customize this report to your needs

        Get 10% FREE Customization

        Customize This Report
        Fact checked
        DMCA.com Protection Status